Related Experiment Video
Updated: May 30, 2026

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
Published on: September 28, 2022
Epstein-Barr virus and multiple sclerosis
R M Lucas1, A M Hughes, M-L J Lay
1National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia. robyn.lucas@anu.edu.au
Abstract:
This review of the considerable evidence linking Epstein-Barr virus (EBV) infection to risk and disease progression in multiple sclerosis (MS) builds on the background to the virus and its interactions with the human host available in the online supplement (see supplement, available online only). The evidence for a similarity in the geographic patterns of occurrence of MS and EBV infection (with infectious mononucleosis or EBV specific serology used as surrogate markers), when reviewed critically, is very limited. There is strong evidence however that people with MS are more likely to report a past history of infectious mononucleosis (thought to represent initial EBV infection at an older age), and higher titres of EBV specific antibodies are associated with an increased risk of developing MS. Elevated levels of the latter are apparent many years before MS onset (compared with non-MS controls) and there is a dose-response relationship between MS risk and antibody titre, with antibodies to the EBV nuclear antigen-1 particularly important. The evidence in relation to EBV DNA load in blood or CSF is conflicting, as is that in relation to T cell responses to EBV. Several hypotheses that have been proposed to explain the links between EBV and MS risk are reviewed and gaps requiring further research are identified.
Insights
Epstein-Barr virus (EBV) infection is strongly linked to an increased risk of developing multiple sclerosis (MS). Higher EBV antibody levels, particularly years before diagnosis, correlate with higher MS risk.
Area of Science:
- Neuroimmunology
- Virology
- Epidemiology
Background:
- Epstein-Barr virus (EBV) is a common human herpesvirus.
- Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system.
Purpose of the Study:
- To review the evidence linking Epstein-Barr virus (EBV) infection to multiple sclerosis (MS) risk and progression.
- To identify gaps in current research regarding the EBV-MS association.
Main Methods:
- Critical review of existing epidemiological and immunological studies.
- Analysis of EBV antibody titers, EBV DNA load, and T cell responses in MS patients and controls.
Main Results:
- Limited evidence for geographic correlation between MS and EBV.
- Strong association between a history of infectious mononucleosis and MS.
- Elevated EBV-specific antibody titers, especially to EBV nuclear antigen-1, are linked to increased MS risk, appearing years before onset.
- Conflicting evidence regarding EBV DNA load and T cell responses.
Conclusions:
- A history of infectious mononucleosis and elevated EBV antibody titers are significant risk factors for MS.
- Further research is needed to elucidate the mechanisms underlying the EBV-MS link and to resolve conflicting findings.
More Related Videos
09:43An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
Published on: March 30, 2018
08:44Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
Related Concept Videos
Multiple Sclerosis l: Introduction
Encephalitis ll: Pathophysiology
Arboviral Encephalitis
Encephalitis l: Introduction
Cytomegalovirus Disease
Viral Meningitis